Table 1.
Model | Activation | EPDC Differentiation | Markers Used for Identification | Time-points | Details | Reference | |
---|---|---|---|---|---|---|---|
WT1CreERT2/+; R26RmTmG | Expansion | SMC Fibro Sporadic EC |
SM-MHC, αSMA, SM22α FN1, ColIII, FSP1, ProCol1 PECAM |
14d # | Tamoxifen: twice weekly for 2-3 weeks, MI one week after final injection | 33 | |
Ad:Msln-Cre; R26RmTmG | n.a. | Fibro | FSP1 | 3d-4wks | Ultrasound-guided virus delivery | 33 | |
WT1CreERT2/+; R26REYFP | Expansion Migration |
CM* | cTnT, sαActin, Cx43, N-Cad, Ca2+ transients Functional coupling |
14d | Tβ4: Pre- and post-MI Tamoxifen: 5 and 3 days pre- MI |
34 | |
Gata5-Cre; R26REYFP | Expansion Migration |
SMC$ EC$ Fibro |
αSMA PECAM ProColI |
7d | Tβ4: Pre- and post-MI | 36 | |
WT1CreERT2/+; R26RmTmG | Expansion | SMC Fibro |
αSMA DDR2, ProCol1, desmin, FSP1, ColIII |
14d | Tamoxifen: twice weekly for 2-3 weeks, MI one week after final injection Tβ4: Post-MI |
38 | |
(BAC)WT1EGFPCre; R26R | Expansion Migration |
SMC EC CM^ Fibro |
αSMA PECAM + location in vessel wall cTnI, SERCA2 via exclusion of other markers |
1mo, 3mo (CM) | 43 | ||
LV-CMVGFP | Migration | CM* | sαActin, morphology | 7d, 21d | Sub-pericardial virus injection | 44 |
other cell types not reported;
comparable results at 1week ,1month and 3 month post-MI;
cells lacked adult CM morphology;
displayed no mature markers, remained rounded.